AWK vs CBIO
American Water Works (AWK) versus Crescent Biopharma, Inc. (CBIO) — a side-by-side from cached financials, not a winner call.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
CBIO does not have a complete income-statement cache yet.
AWK currently screens at market cap $24.31B and trailing P/E 22.1. CBIO currently screens at market cap $491.3M.
Not investment advice. Open the AWK and CBIO stock pages for the full models.
Not investment advice.